Attitudes Towards Buprenorphine and Methadone (Att-1)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Psychiatric University Hospital, Zurich.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Psychiatric University Hospital, Zurich
Information provided by:
Psychiatric University Hospital, Zurich
ClinicalTrials.gov Identifier:
NCT00911846
First received: May 28, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Main intention of this study is to find out whether there is a difference between the attitudes towards opioid- substitution of opioid dependent patients under substitution with methadone, buprenorphine or without substitution and their therapists
| Condition | Intervention |
|---|---|
|
Addictive Opioids |
Other: interview |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Attitudes of Patients With Opioid-Substitution and Their Therapists Towards and Buprenorphine and Methadone |
Resource links provided by NLM:
Drug Information available for:
Methadone
Methadone hydrochloride
Buprenorphine
Buprenorphine hydrochloride
U.S. FDA Resources
Further study details as provided by Psychiatric University Hospital, Zurich:
Primary Outcome Measures:
- Attitude toward buprenorphine compared over the four groups [ Time Frame: one time of measurement ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Treatment success; Treatment conditions; Consumption of substances [ Time Frame: one point of measurement ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 180 |
| Study Start Date: | May 2009 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Buprenorphine
opioid-dependent patients with buprenorphine substitution
|
Other: interview
interview using questionnaires
Other Name: questionnaire attitudes toward substitution
|
|
methadone
opioid-dependent patients substituted with methadone
|
Other: interview
interview using questionnaires
Other Name: questionnaire attitudes toward substitution
|
|
no substitution
opioid-dependent patients without substitution
|
Other: interview
interview using questionnaires
Other Name: questionnaire attitudes toward substitution
|
|
therapists
therapists of the patients
|
Other: interview
interview using questionnaires
Other Name: questionnaire attitudes toward substitution
|
Detailed Description:
Attitudes of patients and therapists can influence therapy success in both directions. Not much is known about patients' and their therapists' attitudes towards substitution medication. Our hypothesis is that the attitude towards buprenorphine is more positive than towards methadone even in patients taking methadone. Better knowledge about the influence of attitudes on treatment success could facilitate to adapt therapy to the patients' needs.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients of therapeutic communities, in- and out-patients and their therapists
Criteria
Inclusion Criteria:
- Age between 18 and 65 years
- Opioid-dependent with substitution with buprenorphine,
- methadone or without substitution
- Sufficient knowledge of German language
Exclusion Criteria:
- Inability to give informed consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00911846
Contacts
| Contact: Ria Leisinger, MD | 0041 44 384 27 87 | ria.leisinger@puk.zh.ch |
| Contact: Rudolf Stohler, MD | 0041 44 205 58 10 | rudolf.stohler@puk.zh.ch |
Locations
| Switzerland | |
| Psychiatric University Hospital | Recruiting |
| Zurich, Kanton Zurich, Switzerland, 8032 | |
| Contact: Ria Leisinger, MD 0041 44 384 27 87 ria.leisinger@puk.zh.ch | |
| Contact: Rudolf Stohler, MD 0041 44 205 58 10 rudolf.stohler@puk.zh.ch | |
| Principal Investigator: Ria Leisinger, MD | |
| Sub-Investigator: Rudolf Stohler, MD | |
| Sub-Investigator: Lukas Boesch, MD | |
Sponsors and Collaborators
Psychiatric University Hospital, Zurich
Investigators
| Study Chair: | Lukas Boesch, PhD | Psychiatric University Hospital, Zurich |
More Information
No publications provided
| Responsible Party: | Ria Leisinger, Psychiatric University Hospital Zurich |
| ClinicalTrials.gov Identifier: | NCT00911846 History of Changes |
| Other Study ID Numbers: | E-10/2009 |
| Study First Received: | May 28, 2009 |
| Last Updated: | May 28, 2009 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by Psychiatric University Hospital, Zurich:
|
opioid dependence substitution buprenorphine methadone "substitution" |
Additional relevant MeSH terms:
|
Buprenorphine Methadone Analgesics, Opioid Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Central Nervous System Depressants Narcotic Antagonists Narcotics Antitussive Agents Respiratory System Agents |
ClinicalTrials.gov processed this record on May 23, 2013